skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines oritavancin diphosphateQuestion & answer

oritavancin diphosphate · Medicine question

Can children receive oritavancin diphosphate?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

The selected product is licensed from 3 months of age. Safety and effectiveness have not been established in younger infants.

Sources for this answer

Tenkasi 400 mg powder for concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 4

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

oritavancin diphosphate

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the oritavancin diphosphate guide

More questions about oritavancin diphosphate

What infections does oritavancin diphosphate treat?Does oritavancin diphosphate treat MRSA?Does oritavancin diphosphate treat Gram-negative infections?How is oritavancin diphosphate given?Can oritavancin diphosphate be taken with food?Why should I tell healthcare staff that I received oritavancin diphosphate?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX